1
|
Sugano K: Screening of gastric cancer in
Asia. Best Pract Res Clin Gastroenterol. 29:895–905. 2015.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Nishizawa M, Seshimo A, Miyake K, Amano K
and Kameoka S: Usefulness of the TRC method in the peritoneal
washing cytology for gastric cancer. Hepatogastroenterology.
61:240–244. 2014.PubMed/NCBI
|
3
|
Li Y, Tan BB, Zhao Q, Fan LQ, Wang D and
Liu Y: ZNF139 promotes tumor metastasis by increasing migration and
invasion in human gastric cancer cells. Neoplasma. 61:291–298.
2014. View Article : Google Scholar : PubMed/NCBI
|
4
|
Katanoda K, Matsuda T, Matsuda A, Shibata
A, Nishino Y, Fujita M, Soda M, Ioka A, Sobue T and Nishimoto H: An
updated report of the trends in cancer incidence and mortality in
Japan. Jpn J Clin Oncol. 43:492–507. 2013. View Article : Google Scholar : PubMed/NCBI
|
5
|
Naito Y, Uchiyama K, Kinoshita Y, Fukudo
S, Joh T, Suzuki H, Takahashi S, Ueno F, Fujiwara Y, Arakawa T, et
al: A questionnaire-based survey on screening for gastric and
colorectal cancer by physicians in East Asian countries in 2010.
Digestion. 86:94–106. 2012. View Article : Google Scholar : PubMed/NCBI
|
6
|
Wang YJ, Liu JZ, Lv P, Dang Y, Gao JY and
Wang Y: Long non-coding RNA CCAT2 promotes gastric cancer
proliferation and invasion by regulating the E-cadherin and LATS2.
Am J Cancer Res. 6:2651–2660. 2016.PubMed/NCBI
|
7
|
Sun Y, Zhang D, Mao M, Lu Y and Jiao N:
Roles of p38 and JNK protein kinase pathways activated by compound
cantharidin capsules containing serum on proliferation inhibition
and apoptosis of human gastric cancer cell line. Exp Ther Med.
14:1809–1817. 2017.PubMed/NCBI
|
8
|
Jia S, Qu T, Feng M, Ji K, Li Z, Jiang W
and Ji J: Association of Wnt1-inducible signaling pathway protein-1
with the proliferation, migration and invasion in gastric cancer
cells. Tumour Biol. 39:10104283176997552017. View Article : Google Scholar : PubMed/NCBI
|
9
|
Liu YY, Chen ZH, Peng JJ, Wu JL, Yuan YJ,
Zhai ET, Cai SR, He YL and Song W: Up-regulation of long non-coding
RNA XLOC_010235 regulates epithelial-to-mesenchymal transition to
promote metastasis by associating with Snail1 in gastric cancer.
Sci Rep. 7:24612017. View Article : Google Scholar : PubMed/NCBI
|
10
|
Zhu M, Zhou X, Du Y, Huang Z, Zhu J, Xu J,
Cheng G, Shu Y, Liu P, Zhu W and Wang T: miR-20a induces cisplatin
resistance of a human gastric cancer cell line via targeting CYLD.
Mol Med Rep. 14:1742–1750. 2016. View Article : Google Scholar : PubMed/NCBI
|
11
|
Wang QP, Wang Y, Wang XD, Mo XM, Gu J, Lu
ZY, Pan ZL and Zhu YX: Survivin up-regulates the expression of
breast cancer resistance protein (BCRP) through attenuating the
suppression of p53 on NF-κB expression in MCF-7/5-FU cells. Int J
Biochem Cell Biol. 45:2036–2044. 2013. View Article : Google Scholar : PubMed/NCBI
|
12
|
Wittkopf N, Günther C, Martini E, He G,
Amann K, He YW, Schuchmann M, Neurath MF and Becker C: Cellular
FLICE-like inhibitory protein secures intestinal epithelial cell
survival and immune homeostasis by regulating caspase-8.
Gastroenterology. 145:1369–1379. 2013. View Article : Google Scholar : PubMed/NCBI
|
13
|
Sikdar S, Mukherjee A, Ghosh S and
Khuda-Bukhsh AR: Condurango glycoside-rich components stimulate DNA
damage-induced cell cycle arrest and ROS-mediated caspase-3
dependent apoptosis through inhibition of cell-proliferation in
lung cancer, in vitro and in vivo. Environ Toxicol Pharmacol.
37:300–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
14
|
Hayakawa Y, Hirata Y, Sakitani K, Nakagawa
H, Nakata W, Kinoshita H, Takahashi R, Takeda K, Ichijo H, Maeda S
and Koike K: Apoptosis signal-regulating kinase-1 inhibitor as a
potent therapeutic drug for the treatment of gastric cancer. Cancer
Sci. 103:2181–2185. 2012. View Article : Google Scholar : PubMed/NCBI
|
15
|
Korbakis D and Scorilas A: Treatment of
gastric cancer cells with 5-fluorouracil/leucovorin and irinotecan
induces distinct alterations in the mRNA expression of the
apoptosis-related genes, including the novel gene BCL2L12. Tumour
Biol. 30:100–107. 2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Zhuo Z, Zhang L, Mu Q, Lou Y, Gong Z, Shi
Y, Ouyang G and Zhang Y: The effect of combination treatment with
docosahexaenoic acid and 5-fluorouracil on the mRNA expression of
apoptosis-related genes, including the novel gene BCL2L12, in
gastric cancer cells. In Vitro Cell Dev Biol Anim. 45:69–74. 2009.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Li Q, Wang JX, He YQ, Feng C, Zhang XJ,
Sheng JQ and Li PF: MicroRNA-185 regulates chemotherapeutic
sensitivity in gastric cancer by targeting apoptosis repressor with
caspase recruitment domain. Cell Death Dis. 24:e11972014.
View Article : Google Scholar
|
18
|
Wu XL, Cheng B, Li PY, Huang HJ, Zhao Q,
Dan ZL, Tian DA and Zhang P: MicroRNA-143 suppresses gastric cancer
cell growth and induces apoptosis by targeting COX-2. World J
Gastroenterol. 19:7758–7765. 2013. View Article : Google Scholar : PubMed/NCBI
|
19
|
Li X, Chen YT, Josson S, Mukhopadhyay NK,
Kim J, Freeman MR and Huang WC: MicroRNA-185 and 342 inhibit
tumorigenicity and induce apoptosis through blockade of the SREBP
metabolic pathway in prostate cancer cells. PLoS One. 8:e709872013.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Qu F, Cui X, Hong Y, Wang J, Li Y, Chen L,
Liu Y, Gao Y, Xu D and Wang Q: MicroRNA-185 suppresses
proliferation, invasion, migration, and tumorigenicity of human
prostate cancer cells through targeting androgen receptor. Mol Cell
Biochem. 377:121–130. 2013. View Article : Google Scholar : PubMed/NCBI
|
21
|
Xiang Y, Ma N, Wang D, Zhang Y, Zhou J, Wu
G, Zhao R, Huang H, Wang X, Qiao Y, et al: miR-152 and miR-185
co-contribute to ovarian cancer cells cisplatin sensitivity by
targeting DNMT1 directly: A novel epigenetic therapy independent of
decitabine. Oncogene. 33:378–386. 2014. View Article : Google Scholar : PubMed/NCBI
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: Defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar : PubMed/NCBI
|
24
|
Li Y, Tan BB, Zhao Q, Fan LQ, Liu Y and
Wang D: Regulatory mechanism of ZNF139 in multi-drug resistance of
gastric cancer cells. Mol Biol Rep. 41:3603–3610. 2014. View Article : Google Scholar : PubMed/NCBI
|
25
|
Zhao LY, Tong DD, Xue M, Ma HL, Liu SY,
Yang J, Liu YX, Guo B, Ni L, Liu LY, et al: MeCP2, a target of
miR-638, facilitates gastric cancer cell proliferation through
activation of the MEK1/2-ERK1/2 signaling pathway by upregulating
GIT1. Oncogenesis. 6:e3682017. View Article : Google Scholar : PubMed/NCBI
|
26
|
Lee H, Saini N, Parris AB, Zhao M and Yang
X: Ganetespib induces G2/M cell cycle arrest and apoptosis in
gastric cancer cells through targeting of receptor tyrosine kinase
signaling. Int J Oncol. 51:967–974. 2017.PubMed/NCBI
|
27
|
Xu X, Wu J, Li S, Hu Z, Xu X, Zhu Y, Liang
Z, Wang X, Lin Y, Mao Y, et al: Downregulation of microRNA-182-5p
contributes to renal cell carcinoma proliferation via activating
the AKT/FOXO3a signaling pathway. Mol Cancer. 13:1092014.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Wang HY, Shen J, Jiang CP and Liu BR: How
to explain the contradiction of microRNA 200c expression and
survival in solid tumors? A meta-analysis. Asian Pac J Cancer Prev.
15:3687–3690. 2014. View Article : Google Scholar : PubMed/NCBI
|
29
|
Li W, Jin X, Deng X, Zhang G, Zhang B and
Ma L: The putative tumor suppressor microRNA-497 modulates gastric
cancer cell proliferation and invasion by repressing eIF4E. Biochem
Biophys Res Commun. 449:235–240. 2014. View Article : Google Scholar : PubMed/NCBI
|
30
|
Yuan W, Xiaoyun H, Haifeng Q, Jing L,
Weixu H, Ruofan D, Jinjin Y and Zongji S: MicroRNA-218 enhances the
radiosensitivity of human cervical cancer via promoting radiation
induced apoptosis. Int J Med Sci. 11:691–696. 2014. View Article : Google Scholar : PubMed/NCBI
|
31
|
Sun Z, Zhang Z, Liu Z, Qiu B, Liu K and
Dong G: MicroRNA-335 inhibits invasion and metastasis of colorectal
cancer by targeting ZEB2. Med Oncol. 31:9822014. View Article : Google Scholar : PubMed/NCBI
|
32
|
Yang SM, Huang C, Li XF, Yu MZ, He Y and
Li J: miR-21 confers cisplatin resistance in gastric cancer cells
by regulating PTEN. Toxicology. 306:162–168. 2013. View Article : Google Scholar : PubMed/NCBI
|
33
|
Li ZH, Pan XM, Han BW, Guo XM, Zhang Z,
Jia J and Gao LB: A let-7 binding site polymorphism rs712 in the
KRAS 3′ UTR is associated with an increased risk of gastric cancer.
Tumour Biol. 34:3159–3163. 2013. View Article : Google Scholar : PubMed/NCBI
|
34
|
Zhao X, Yang L and Hu J: Down-regulation
of miR-27a might inhibit proliferation and drug resistance of
gastric cancer cells. J Exp Clin Cancer Res. 30:552011. View Article : Google Scholar : PubMed/NCBI
|
35
|
Zhi Q, Zhu J, Guo X, He S, Xue X, Zhou J,
Hu B, Li H, Chen S, Zhao H and Kuang Y: Metastasis-related miR-185
is a potential prognostic biomarker for hepatocellular carcinoma in
early stage. Biomed Pharmacother. 67:393–398. 2013. View Article : Google Scholar : PubMed/NCBI
|
36
|
Qiu F, Xiong JP, Deng J and Xiang XJ:
TRIM29 functions as an oncogene in gastric cancer and is regulated
by miR-185. Int J Clin Exp Pathol. 8:5053–5061. 2015.PubMed/NCBI
|
37
|
Yoon JH, Choi WS, Kim O, Choi BJ, Nam SW,
Lee JY and Park WS: Gastrokine 1 inhibits gastric cancer cell
migration and invasion by downregulating RhoA expression. Gastric
Cancer. 20:274–285. 2017. View Article : Google Scholar : PubMed/NCBI
|
38
|
Golestani Eimani B, Sanati MH, Houshmand
M, Ataei M, Akbarian F and Shakhssalim N: Expression and prognostic
significance of bcl-2 and bax in the progression and clinical
outcome of transitional bladder cell carcinoma. Cell J. 15:356–363.
2014.PubMed/NCBI
|
39
|
Wu S, Liu B, Zhang Q, Liu J, Zhou W, Wang
C, Li M, Bao S and Zhu R: Dihydromyricetin reduced Bcl-2 expression
via p53 in human hepatoma HepG2 cells. PLoS One. 8:e768862013.
View Article : Google Scholar : PubMed/NCBI
|
40
|
Li S, Sun J, Yang J, Zhang L, Wang L, Wang
X and Guo Z: XIAP expression is associated with pancreatic
carcinoma outcome. Mol Clin Oncol. 1:305–308. 2013. View Article : Google Scholar : PubMed/NCBI
|
41
|
Chui YL, Ma CH, Li W, Xu Z, Yao Y, Lin FK,
Chan JY and Lee KK: Anti-apoptotic protein BRE/BRCC45 attenuates
apoptosis through maintaining the expression of caspase inhibitor
XIAP in mouse Lewis lung carcinoma D122 cells. Apoptosis.
19:829–840. 2014. View Article : Google Scholar : PubMed/NCBI
|
42
|
Xu M, Xia LP, Fan LJ, Xue JL, Shao WW and
Xu D: Livin and caspase-3 expression are negatively correlated in
cervical squamous cell cancer. Eur J Gynaecol Oncol. 34:152–155.
2013.PubMed/NCBI
|
43
|
Yang D, Song X, Zhang J, Ye L, Wang S, Che
X, Wang J, Zhang Z and Wang L: Suppression of livin gene expression
by siRNA leads to growth inhibition and apoptosis induction in
human bladder cancer T24 cells. Biosci Biotechnol Biochem.
74:1039–1044. 2010. View Article : Google Scholar : PubMed/NCBI
|
44
|
Sikdar S, Mukherjee A, Ghosh S and
Khuda-Bukhsh AR: Condurango glycoside-rich components stimulate DNA
damage-induced cell cycle arrest and ROS-mediated caspase-3
dependent apoptosis through inhibition of cell-proliferation in
lung cancer, in vitro and in vivo. Environ Toxicol Pharmacol.
37:300–314. 2014. View Article : Google Scholar : PubMed/NCBI
|